«Back

Class 2 Recall on Mepacrine Hydrochloride 100 Mg Tablets

Class 2 Recall on Mepacrine Hydrochloride 100 Mg Tablets

BCM Specials Limited has informed us that a number of foreign body particulates including glass and rubber have been found in one of the containers of the Active Pharmaceutical Ingredient (API) used in the manufacture of Mepacrine Hydrochloride 100mg tablets. A small amount of the affected API (comparative to the API present in batch 85641) has been used in the manufacture of batch 85641 Mepacrine Hydrochloride tablets.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code Product Description Supplier Affected Batch
8463366 MEPACRINE TABS 100MG BCM Specials Limited 85641

For stock control queries please contact BCM Specials Limited., Telephone +44 (0)115 968 6075 or email specials.regulatory.bcm@fareva.com.

For any medical information enquires please contact BCM Specials Limited., Telephone +44 (0)115 968 6075 or email specials.regulatory.bcm@fareva.com.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.